AgomAb Therapeutics NV American Depositary Shares (AGMB) — Tangible Net Worth Ratio
AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Tangible Net Worth Ratio of 86.3% as of March 2026. This metric is calculated by deducting intangible assets ($20.11 Million) from net assets ($146.93 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore AGMB net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
AgomAb Therapeutics NV American Depositary Shares Tangible Net Worth Ratio (2021–2025)
This chart shows how AgomAb Therapeutics NV American Depositary Shares's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 86.3%, reflecting net assets of $146.93 Million with intangible assets of $20.11 Million USD. For live market cap and overall valuation, see AgomAb Therapeutics NV American Deposita stock valuation.
Annual Tangible Net Worth Ratio for AgomAb Therapeutics NV American Depositary Shares (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See AGMB FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.6% | $130.90 Million | $20.11 Million | $153.71 Million | ▼ -4.7 pp |
| 2024 | 89.3% | $188.08 Million | $20.11 Million | $206.36 Million | ▲ +2.6 pp |
| 2023 | 86.7% | $151.44 Million | $20.11 Million | $171.26 Million | ▲ +17.1 pp |
| 2022 | 69.6% | $66.25 Million | $20.11 Million | $101.00 Million | ▲ +17.1 pp |
| 2021 | 52.5% | $42.36 Million | $20.11 Million | $84.00 Million | — |